What About AbbVie?
Published on: 11/05/2020
Pharmaceutical giant AbbVie has weathered the COVID-19 storm relatively well, with its first-quarter revenue and earnings per share both coming in ahead of
AbbvieCOVID-19DividendsEarningsInvestRevenueStock MarketStocks2020 Stock PicksCoronavirusCoronavirus PandemicCOVID-19 PandemicStock MarketStock PicksStocks to Watch
